๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Efficacy and Safety of HN2301 in Autoimmune Diseases๏ผˆAIDs๏ผ‰
NCT06801119Systemic Lupus Erythematosus, Scleroderma, Rheumatoid Arthritis
Shenzhen MagicRNA Biotechnology Co., Ltd
Phase 1
30
Hefei
2025-03-16
Not yet open
Three-in-One Stop Computed Topography Angiography(CTA) and CT Perfusion(CTP) in Cerebrovascular Disease
NCT06890468Radiology, Vascular Diseases
Xin Lou
Observational
1,000
Beijing
2025-03-16
Active, closed
Efficacy of Esketamine Combined With Different General Anesthetics on Quality of Postoperative Recovery
NCT06976996Quality of Postoperative Recovery
Northern Jiangsu People's Hospital
Not applicable
190
Yangzhou
2025-03-16
Recruiting
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
NCT06841354Triple Negative Breast Neoplasms
Merck Sharp & Dohme LLC
Phase 3
1,000
Bengbu, Chongqing, Xiamen, Guangzhou, Nanning, Zhengzhou, Wuhan, Xiangyang
2025-03-16
By invitation
A Study On The Prediction of Neoadjuvant Efficacy For Rectal Cancer Based On MR Cytometry Imaging and Deep-radiomics
NCT07107815Rectal Cancer, Adenocarcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
250
Beijing
2025-03-15
Not yet open
Study on the Enhancement of Intestinal and Immune Functions Through Probiotic Intervention
NCT06863415Healthy
Wecare Probiotics Co., Ltd.
Not applicable
90
Zhengzhou
2025-03-15
Recruiting
MT027 Cell Injection in Patients With Advanced Primary or Secondary Peritoneal Tumors
NCT07004647Peritoneal Tumor
Ruijin Hospital
Not applicable
10
Shanghai
2025-03-15
Not yet open
A Clinical Study of Pelvic Concurrent Chemoradiotherapy Combined with CT-guided Intracavitary Brachytherapy with Adaptive Simultaneous Dose Escalation for Locally Advanced Cervical Cancer
NCT06882473Locally Advanced Cervical Cancer
Peking University Third Hospital
Not applicable
20
Beijing
2025-03-15
Recruiting
Iparomlimab and Tuvonralimab Combined With Paclitaxel and Cisplatin as Neoadjuvant Therapy for CC
NCT06878222Cervical Cancers
Obstetrics & Gynecology Hospital of Fudan University
Phase 2
35
Shanghai
2025-03-15
Recruiting
Phase II Study of PD-1 Inhibitor Combined With Apatinib and Mitotane in the Treatment of Advanced Adrenal Cortical Carcinoma
NCT06831175Adrenal Cortical Carcinoma, Adrenal Cortical Cancer, Adrenal Cancer
West China Hospital
Phase 2
28
Chengdu
2025-03-15
Active, closed
A Randomized Clinical Trial on the Effectiveness of Novel Plano Spectacle Lenses on Myopia Prevention in Pre-myopic Children
NCT06860737Myopic Children
Shanghai Eye Disease Prevention and Treatment Center
Not applicable
388
Shanghai
2025-03-15
Recruiting
Nocardia Rubra Cell Wall Skeleton in Combination With Prior Second- or Third-line Regimens for the Treatment of Potentially Hazardous Colorectal Cancer SD Status
NCT06356714Colorectal Cancer, Colorectal Neoplasms
Sun Jing
Phase 2
22
Nanjing
2025-03-15
Recruiting
Chiglitazar Sodium Combined With Venetoclax and Azacitidine (CVA) for the Treatment of R/R AML
NCT06737523Acute Myeloid Leukemia, Relapse, Refractory AML
The First Affiliated Hospital of Xiamen University
Phase 1
30
Xiamen
2025-03-15
Recruiting
Application of CfDNA Methylation Detection in Auxiliary Diagnosis of Breast Cancer
NCT06876610Breast Cancer Screening
Geneplus-Beijing Co. Ltd.
Observational
200
Beijing
2025-03-15
Recruiting
Longitudinal Cohort Study on Invasive Fungal Disease After Allogeneic Hematopoietic Stem Cell Transplantation
NCT07569055Invasive Fungal Disease, Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Peking University People's Hospital
Observational
6,000
Beijing
2025-03-15
By invitation
Exploration of Repeated High-frequency Transcranial Magnetic Stimulation for the Treatment of Acute Phase Aphasia in Post-stroke Patients
NCT06787508Stroke, Aphasia, Control Patients
First Affiliated Hospital of Chongqing Medical University
Not applicable
70
Chongqing
2025-03-15
Not yet open
Reducing Pneumonia with LMA in Lung Wedge Resection
NCT06873958Pneumonia, Postoperative, Anesthesia, Thoracic Surgery, Thoracoscopic Wedge Resection
Hai Feng
Observational
700
Jinan
2025-03-15
Recruiting
Randomized Controlled Trial of Berberine in Combination With Doxycycline in the Treatment of Chronic Endometritis
NCT07180563Chronic Endometritis
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Phase 1/2
206
Yiwu
2025-03-15
Not yet open
AI-Guided Stress Management Breathing Practices Via a Wearable Device
NCT06881875Stress Reduction
Peking University
Not applicable
120
Beijing
2025-03-15
By invitation
Adjuvant Immunotherapy Combined With ChemoRadiation for Patients With High-risk Resectable Extrahepatic Cholangiocarcinoma๏ผˆAICRC๏ผ‰
NCT06997913Lymph Node Metastasis, Neurovascular Invasion, Pathology Showed R1 Resection
Hengchao Yu
Observational
10
XiAn
2025-03-15
Not yet open
Impact of Structural and Microenvironmental Abnormalities in Olfactory Cleft on Olfaction in CRS
NCT06834477Chronic Rhinosinusitis (CRS)
Peking University Third Hospital
Observational
80
Beijing
2025-03-14
Active, closed
A Study to Determine the Efficacy, Safety, and Durability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration
NCT06795048Neovascular Age-related Macular Degeneration (nAMD)
Hoffmann-La Roche
Phase 4
274
Beijing, Chengdu, Guangzhou, Shanghai, Wuhan
2025-03-14
Recruiting
A Study of Efficacy and Safety of AND017 in Patients With Myelodysplastic Syndrome
NCT06304103Myelodysplastic Syndromes
Kind Pharmaceuticals LLC
Phase 2
63
Hangzhou
2025-03-14
Recruiting
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
NCT06677060Heart Failure
AstraZeneca
Phase 3
11,300
Baotou, Beijing, Changchun, Changde, Changsha, Changzhou, Chengdu, Chifeng
2025-03-14
Recruiting
Application of Remimazolam Combined With Esketamine in Painless Gastroscopy and Colonoscopy in Elderly Patients
NCT07002801Gastrointestinal Disease
Harbin Medical University
Not applicable
280
Harbin
2025-03-14
Recruiting
Phase II Study of PD-1 Antibody Combined With Radiotherapy in Recurrent or Metastatic Adrenal Cortical Carcinoma
NCT06587802Adrenocortical Carcinoma
Sun Yat-sen University
Phase 2
18
Guangzhou
2025-03-14
Recruiting
Diagnostic Efficacy and Safety of Flotufolastat F-18 Injection in Subjects With Biochemical Recurrence of Prostate Cancer
NCT07115277Prostate Cancer
Sinotau Pharmaceutical Group
Not applicable
121
Beijing
2025-03-14
Not yet open
The Effect of Modified Olfactory Training on Postoperative Olfactory Dysfunction in Patients With CRS
NCT06837051Olfactory Dysfunction, Chronic Rhinosinusitis
Peking University Third Hospital
Not applicable
213
Beijing
2025-03-14
Active, closed
A Phase Ib Study of RC148 as Monotherapy or Combination for Locally Advanced or Metastatic NSCLC
NCT06883630Non-Small Cell Lung Cancer
RemeGen Co., Ltd.
Phase 1
121
Beijing, Foshan, Guangzhou, Jiangmen, Gulin, Nanning, Harbin, Hanyang
2025-03-13
Recruiting
A Long-term Follow up Study of EXG102-031 in Participants With wAMD
NCT06859515Wet Age-related Macular Degeneration
Guangzhou Jiayin Biotech Ltd
Observational
42
Beijing
2025-03-13
Recruiting
A Clinical Trial of TQB2102 for Injection in Gynecological Tumors With Recurrent/Metastatic Advanced
NCT06798207Gynecological Tumors
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Phase 2
170
Beijing, Chongqing, Fuzhou, Lanzhou, Guangzhou, Meizhou, Qingyuan, Nanning
2025-03-13
Recruiting
The Effects of Dynamic Taping Combined With Corrective Exercises on Cervical Proprioception and Muscle Imbalance in Patients With Upper Crossed Syndrome
NCT07182461Upper Crossed Syndrome
China Medical University Hospital
Not applicable
36
2025-03-13
Recruiting
A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic Arthritis
NCT06869551Juvenile Psoriatic Arthritis
Bristol-Myers Squibb
Phase 3
60
Beijing, Chongqing, Guangzhou, Nanjing, Changchun, Hangzhou, Shanghai
2025-03-13
Recruiting
A Study of SHR-A1811 in Subjects With Ovarian Cancer
NCT06828354Ovarian Cancer
Jiangsu HengRui Medicine Co., Ltd.
Phase 3
300
Wuhan, Jinan
2025-03-13
Recruiting
Safety and Immunogenicity of the Recombinant Zoster Vaccine, LYB004 in Adults Aged 40 Years and Older
NCT06874842Herpes Zoster (HZ)
Guangzhou Patronus Biotech Co., Ltd.
Phase 1
92
Meizhou
2025-03-13
Active, closed
Fenofibrate in Subjects With Primary Biliary Cholangitis (PBC)
NCT07104201Primary Biliary Cholangitis (PBC)
Xijing Hospital of Digestive Diseases
Phase EARLY_PHASE1
15
Xi'an
2025-03-13
Recruiting
Study on the Accuracy of Determining the Responsible Vessel in Medium Vessel Occlusive Stroke Based on Multi-type CT Evaluation
NCT07347587Stroke
Xuanwu Hospital, Beijing
Observational
622
Beijing
2025-03-13
Recruiting
Lecanemab for Early Onset Familial Alzheimer's Disease
NCT06883019Alzheimer Disease
RenJi Hospital
Observational
114
Beijing, Guangdong, Guizhou, Jiangsu, Shanghai, Sichuan, Tianjin, Zhejiang
2025-03-13
Active, closed
METR-NK Cells in Combination With Anti-angiogenic Neoadjuvant Therapy for Advanced Epithelial Ovarian Cancer
NCT06884345Ovarian Cancer
Anhui Provincial Cancer Hospital
Phase 1/2
28
Hefei
2025-03-13
Active, closed
A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer
NCT06764485Metastatic Castration-resistant Prostate Cancer
Celgene
Phase 3
960
Hefei, Beijing, Fuzhou, Xiamen, Guangzhou, Huizhou, Changzhou, Nanjing
2025-03-13
Recruiting
Managing Pregnancy Pain With Baduanjin Exercise
NCT07153653Pregnancy-related Low Back and Pelvic Pain, Pregnancy
Peking Union Medical College Hospital
Not applicable
84
Beijing
2025-03-13
Recruiting
Trial of JMKX003142 in Participants With Rapidly Progressive Autosomal Dominant Polycystic Kidney Disease (ADPKD)
NCT06800651ADPKD (Autosomal Dominant Polycystic Kidney Disease)
Jemincare
Phase 2
135
Beijing
2025-03-13
Active, closed
Safety and Efficacy of HCB101 in Combination With Multiple Agents in Patients With Advanced Solid Tumors
NCT06771622Solid Cancer
FBD Biologics Limited
Phase 1/2
500
Jinan
2025-03-13
Recruiting
HS-20089 for Injection in Patients With Platinum-Resistant Recurrent Epithelial Ovarian Cancer
NCT06855069Ovarian Cancer
Hansoh BioMedical R&D Company
Phase 3
468
Beijing
2025-03-13
Recruiting
A Phase II Clinical Study to Evaluate the Efficacy and Safety of Technetium [99mtc]-H7ND Injection in the Diagnosis of Peritoneal Metastasis of Gastrointestinal Malignant Tumor.
NCT07107633Solid Tumor, Peritoneal Metastasis
Jiaxing Pharmadax Genesis Pharmaceutical Technology Co.,Ltd.
Phase 2
90
Shanghai
2025-03-12
Recruiting
Bioequivalence Study of Paclitaxel for Injection (Albumin Bound) in Subjects With Breast Cancer
NCT06765590Breast Cancer
Sichuan Huiyu Pharmaceutical Co., Ltd
Not applicable
24
Luoyang
2025-03-12
Recruiting
A Single-Arm, Phase II Clinical Trail of Cadonilimab Combined With Chemoradiotherapy in Oligometastatic Stage IVB Cervical Cancer
NCT06998394Cervical Cancer Stage IV
Xiangbo Wan
Phase 2
30
Zhengzhou
2025-03-12
By invitation
A Phase III Clinical Study of QY201 Tablet in Subjects With Moderate to Severe Atopic Dermatitis.
NCT07180511Atopic Dermatitis (AD)
E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd.
Phase 3
460
Hangzhou
2025-03-12
Recruiting
Clinical Trial of TQB2825 Injection Combined With Chemotherapy in Subjects With Diffuse Large B-cell Lymphoma
NCT06854445Diffuse Large Cell B-lymphoma
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
Phase 2
55
Wuhu, Xiamen, Lanzhou, Guangzhou, Nanning, Shijiazhuang, Harbin, Zhengzhou
2025-03-12
Recruiting
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
NCT06792695Metastatic Colorectal Cancer
AstraZeneca
Phase 2
80
Beijing, Chengdu, Harbin, Shanghai, Wuhan, Zhengzhou
2025-03-12
Active, closed
Single-ascending Dose Study of Kylo-12 in Healthy Subjects
NCT06783881Hypertriglyceridemia
Kylonova (Xiamen) Biopharma co., LTD.
Phase 1
50
Chengdu
2025-03-12
Not yet open
A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Advanced Pancreatic Cancer
NCT06866977Pancreatic Cancer
Xiangya Hospital of Central South University
Phase 1/2
10
Changsha
2025-03-12
Recruiting
Effect of Bone Augmentation Simultaneous to Implant Removal on the Prognosis of Reimplantation at the Same Site
NCT07078890Implant Failure, Bone Augmentation, Prognosis
The Dental Hospital of Zhejiang University School of Medicine
Not applicable
40
Wuhan, Hangzhou, Shanghai
2025-03-12
Recruiting
Real-World Study on Nano-Crystalline Megestrol Acetate for Cachexia in TKI-Treated Advanced Digestive Tumors
NCT06940102Cachexia, Digestive System Cancer, Gastric Cancer, Colorectal Cancer
Changchun GeneScience Pharmaceutical Co., Ltd.
Observational
120
Shenyang
2025-03-12
By invitation
Efficacy and Safety of Sintilimab Combined with Platinum-containing Double-agent Chemotherapy in First-line Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer in Elderly Patients
NCT06883136Non-Small Cell Lung Cancer
Qianfoshan Hospital
Observational
43
Jinan
2025-03-12
Recruiting
A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)
NCT06615479Relapsed or Refractory Multiple Myeloma (RRMM)
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Phase 3
440
2025-03-12
Recruiting
Development and Application of Accurate Detection Technology Based on Multimodal Data of Breast Cancer Comobid Depression
NCT06938373Breast Neoplasms
Xiangya Hospital of Central South University
Observational
1,000
Changsha
2025-03-11
Recruiting
Orelabrutinib Combined With Rituximab as First-line Systemic Treatment for Marginal Zone Lymphoma
NCT07022223Marginal Zone Lymphoma(MZL)
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
51
Hangzhou, Dongyang, Huzhou, Jiaxing, Lishui, Ningbo, Quzhou, Shaoxing
2025-03-11
Recruiting
A Multicenter Randomized Controlled Phase II Trial of Iparomlimab and Tuvonralimab (QL1706) Combined With SOX Chemotherapy Versus Chemotherapy Alone in the Treatment of Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
NCT06829797Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma
Shandong Provincial Hospital
Phase 2
96
Jinan
2025-03-11
Recruiting
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
NCT06641466Menstrual Migraine
Pfizer
Phase 3
723
Beijing, Chongqing, Shijiazhuang, Nanjing, Suzhou, Xi'an, Xianyang, Shanghai
2025-03-11
Recruiting
Establishment of a Longitudinal Cohort for Newborns With Low Apgar Scores at Birth
NCT06961123Low Apgar Scores
Peking University Third Hospital
Observational
600
Beijing
2025-03-11
Recruiting
A Study of SRSD107 in Participants With Chronic Coronary and/or Peripheral Arterial Disease
NCT07318155Coronary Artery Disease (CAD), Peripheral Arterial Disease
Sirius Therapeutics Co., Ltd.
Phase 2
104
Beijing
2025-03-11
Recruiting
Newly-diagnosed Pediatric T-cell ALL Protocol
NCT06855810Acute Lymphoblastic Leukemia, Childhood Leukemia, Acute Lymphoblastic, T Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
Institute of Hematology & Blood Diseases Hospital, China
Phase 2/3
610
Hefei, Chongqing, Fuzhou, Guangzhou, Nanning, Guiyang, Wuhan, Changsha
2025-03-11
By invitation
Diagnostic Accuracy of Endocytoscopy for Superficial Esophageal Neoplasia
NCT06984055Esophageal Cancer, Squamous Cell
Changhai Hospital
Observational
600
Shanghai
2025-03-11
Recruiting
Confocal Laser Endomicroscopy Guided Medical Thoracoscopy for the Diagnosis of Pleural Disease
NCT06741839Pleural Diseases, Pleural Effusion
China-Japan Friendship Hospital
Not applicable
158
Beijing
2025-03-11
Recruiting
A Study on the Peripheral Blood in Patients With Acute Coronary Syndrome
NCT06955143Acute Coronary Syndrome, Chronic Coronary Syndrome
Second Affiliated Hospital of Wenzhou Medical University
Observational
310
Lishui
2025-03-11
Recruiting
Universal CAR-T Cell Therapy for NHL
NCT07248163Non-hodgkin Lymphoma,B Cell
Bioray Laboratories
Not applicable
6
Shanghai
2025-03-11
Not yet open
Therapeutic Effect of Upadacitinib in Primary Sjรถgren's Syndrome
NCT06862284Primary Sjรถgren's Syndrome (pSS)
Peking University People's Hospital
Phase 2
30
Beijing
2025-03-10
Active, closed
Zoledronic Acid Combined With EC-T for Triple-Negative Breast Cancer
NCT06876636Breast Cancer Metastatic
Xijing Hospital
Not applicable
99
Xi'an
2025-03-10
Recruiting
A Study of BL0175 Injection in Postmenopausal Female Adults With HR-positive, Locally Advanced or Metastatic Cancer
NCT06738966Breast Cancer, Ovarian Cancer, Endometrial Cancer
Shanghai Best-Link Bioscience, LLC
Phase 1
9
Changchun, Jinan
2025-03-10
Recruiting
Translation and Validation of Chinese COMPAT-SF
NCT06917716Chronic Pancreatitis
Changhai Hospital
Observational
356
Shanghai
2025-03-10
Active, closed
The Study of Postoperative Delirium and Glymphatic System Function in Cardiac Surgery
NCT06901479Postoperative Delirium (POD)
Nanjing First Hospital, Nanjing Medical University
Observational
200
Nanjing
2025-03-10
By invitation
The Effects of Knee Brace and Muscle Training on Osteoarthritis Patients
NCT07246109Osteoarthritis (OA) of the Knee
China Medical University Hospital
Not applicable
40
2025-03-10
Recruiting
A Clinical Study Evaluating the Safety and Efficacy of GT719 Universal Cell Injection in Adult Participants With Relapsed/Refractory CD19-positive B-cell Malignant Hematological Tumors
NCT07131254Hematological Malignancy (Leukemia- Lymphoma)
Grit Biotechnology
Phase EARLY_PHASE1
34
Ganzhou
2025-03-10
Not yet open
Investigating the Efficacy of Probiotics in Enhancing Gastrointestinal and Immunological Health
NCT06886724Intestinal and Lmmune Function Lmproved
Wecare Probiotics Co., Ltd.
Not applicable
40
Zhengzhou
2025-03-10
Active, closed
Safety and Efficacy Evaluation of Anti IGF-1R Monoclonal Antibody Combined With Anti-PD-1 Monoclonal Antibody in Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer
NCT06866548mCRPC
Shanghai Changzheng Hospital
Phase EARLY_PHASE1
7
Shanghai
2025-03-10
Recruiting
Drug-induced Kidney Injury Model
NCT06939387Acute Kidney Injury
Zhejiang Provincial People's Hospital
Observational
1,500
Hangzhou
2025-03-10
Recruiting
Hypofractionated Radiotherapy Plus Immunotherapy Versus Conventional Radiotherapy in Locally Recurrent Rectal Cancer
NCT06928584Locally Recurrent Rectal Cancer
Fudan University
Phase 2
221
Shanghai
2025-03-10
Recruiting
Proton Therapy for Recurrent Nasopharyngeal Carcinoma
NCT07412314Recurrent Nasopharyngeal Carcinoma
Guangzhou Concord Cancer Center
Not applicable
52
Guangzhou, Guanzhou
2025-03-10
Not yet open
Xingbai Ji Formula Combined with Chemotherapy and Sintilimab in Metastatic Multi-Target Mutation-Negative Non-Small Cell Lung Cancer: a Clinical Trial
NCT06848426Non-Small Cell Lung Cancer, Non-small Cell Lung Cancer Recurrent, Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV
Jiangxi Provincial People's Hopital
Not applicable
100
Nanchang
2025-03-10
Recruiting
Chemo-immunotherapy for Cervical Cancer Stage IIICp Trial
NCT07167160Cervical Cancer, Immunochemotherapy
Women's Hospital School Of Medicine Zhejiang University
Phase 2
59
Hangzhou
2025-03-10
Not yet open
Postoperative Adjuvant Therapy for CT041 Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma Patients
NCT06857786Gastroesophageal Junction Adenocarcinoma, Gastric Adenocarcinoma
Peking University
Phase 1
48
Beijing, Nanjing
2025-03-10
Active, closed
Exploring the Optimal Concentration of Lidocaine Test Dose for Labor Analgesia
NCT06819579Labor Pain
The Second Affiliated Hospital of Chongqing Medical University
Not applicable
99
Chongqing
2025-03-10
Recruiting
A Long-term Extension Clinical Study of TLL-018 in Patients With Rheumatoid Arthritis
NCT06887127Rheumatoid Arthritis
Hangzhou Highlightll Pharmaceutical Co., Ltd
Phase 3
350
Beijing
2025-03-10
Recruiting
A Clinical Study of IMC-001 for Injection in Improving Atherosclerotic Plaque Stability in Patients With Acute Coronary Syndrome.
NCT06788431Atherosclerosis
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Phase EARLY_PHASE1
18
Nanyang, Shanghai
2025-03-10
Recruiting
Neoadjuvant Chemotherapy Plus Cadonilimab for Locally Advanced Cervical Cancer
NCT07104149Female, Age โ‰ฅ 18 Years Old, No Previous Systemic Treatment for the Current Disease, Including Surgery, Antitumor Radiochemotherapy/Immunotherapy, ECOG Score of 0-1, Histologically Confirmed Cervical Cancer, FIGO Stage IB3, IIA2, IIB, IIIC, and Assessed by the Researcher as Resectable Lesion
The First Affiliated Hospital of Zhengzhou University
Phase 2
29
Zhengzhou
2025-03-10
Not yet open
Research on the Improvement of Intestinal and Immune Functions by Probiotics
NCT06873425Intestinal Health
Wecare Probiotics Co., Ltd.
Not applicable
40
Zhengzhou
2025-03-10
Recruiting
The Clinical Study of Synaptic Plasticity-based Lencanumab for the Treatment of Early Alzheimer's Disease
NCT06871839Alzheimer's Disease, Lecanemab, Functional Magnetic Resonance Imaging
Cuibai Wei๏ผŒClinical Professor
Observational
120
Beijing
2025-03-10
Not yet open
Research on the Role of Probiotics in Human Intestinal Health
NCT06886711Intestinal Microbiota
Wecare Probiotics Co., Ltd.
Not applicable
45
Zhengzhou
2025-03-10
Not yet open
ctDNA-guided First-line Immuno-de-escalation Therapy for IVB-stage and Recurrent Cervical Cancer
NCT06878196Uterine Cervical Neoplasm
Obstetrics & Gynecology Hospital of Fudan University
Not applicable
20
Shanghai
2025-03-10
By invitation
Clinical Trial to Assess the Safety and Efficacy of EXG001-307 in Patients With Spinal Muscular Atrophy
NCT06888661Spinal Muscular Atrophy (SMA)
Guangzhou Jiayin Biotech Ltd
Phase EARLY_PHASE1
4
Shanghai
2025-03-10
Recruiting
Safety , Feasibility and Preliminary Efficacy of Remote Ischemic Conditioning in Patients With Aneurysmal Subarachnoid Hemorrhage After Aneurysm Clipping
NCT06819657Subarachnoid Hemorrhage, Aneurysmal, Cerebrovascular Disorders, Brain Diseases, Stroke
Beijing Tiantan Hospital
Not applicable
40
Beijing
2025-03-10
Recruiting
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
NCT06671496Psoriatic Arthritis
Takeda
Phase 3
600
Bengbu, Beijing, Xiamen, Guangzhou, Shenzhen, Luoyang, Wuhan, Zhuzhou
2025-03-10
By invitation
Effects of Different Exercises on Intrahepatic Lipid in Patients With Metabolic Dysfunction-associated Steatotic Liver Disease
NCT06994871Metabolic Dysfunction-Associated Steatotic Liver Disease
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Not applicable
186
Nanjing
2025-03-09
Recruiting
Hypofractionated Radiotherapy Combined With NALIRIF, PD-1 Antibody in Locally Recurrent Rectal Cancer(NOVELTY-R)
NCT07183865Locally Recurrent Rectal Cancer
Fudan University
Phase 2
44
Shanghai
2025-03-09
Recruiting
A Study to Evaluate the Safety, Tolerability and PK of SK-08
NCT07021157Chronic Kidney Disease(CKD)
Consun Pharmaceutical Group
Phase 1
48
Hangzhou
2025-03-09
Not yet open
Pucotenlimab Combined with MRG002 for HER2-positive Cancer of Unknown Primary
NCT06869174Cancer of Unknown Primary
Zhiguo Luo, MD, PhD
Phase 2
50
Shanghai
2025-03-08
Recruiting
Multicenter Single-Arm Study of Ivonescimab (AK112) Combined with Chemotherapy in Pretreated Pleural Mesothelioma
NCT06875076Pretreated Pleural Mesothelioma
The First Hospital of Jilin University
Phase 2
25
Changchun
2025-03-08
Recruiting
Study of YK012 in Primary Membranous Nephropathy
NCT06982729Primary Membranous Nephropathy
Excyte Biopharma Ltd
Phase 1
72
Beijing
2025-03-08
Active, closed
Emulsion 8-Week Anti-acne Efficacy Clinical Study
NCT06985745Female, Male, Acne
ChinaNorm
Not applicable
66
Shanghai
2025-03-08
Rows per page Showing 9001–9100 of 19052
Previous 89 90 91 92 93 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 22 September 2026. https://priyalifescience.com/clinical-trials-china?page=91

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.